Verifying…
Home / Drug A–Z / Bicillin Injection## (strength format)

Bicillin Injection## (strength format)

NAFDAC Reg. No. 04-3787 · Drug

Registered with NAFDAC. Registration activeAs of 28 October 2026 · synced automatically from official sources.
Product
Bicillin Injection## (strength format)
NAFDAC number
04-3787
Active ingredient
Procaine Benzylpenicillin; Benzylpenicillin Sodium
Strength
3000000IU+1000000UI
Form
Injection
Pack size
1 x 18 mL (in vial)
Manufacturer
Not listed
Applicant (holder)
Clarion Medicals Limited
Approved
21 Dec 2023
Status
Active View on NAFDAC ↗
Registration valid to
20 Dec 2028
WHO alerts
None found
Community reports
None
Times checked
0

What we found

  • Bicillin Injection## (strength format) is on the NAFDAC register with an active registration (04-3787). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Bicillin Injection## (strength format)

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Serious warning: NOT FOR INTRAVENOUS USE. DO NOT INJECT INTRAVENOUSLY OR ADMIX WITH OTHER INTRAVENOUS SOLUTIONS. THERE HAVE BEEN REPORTS OF INADVERTENT INTRAVENOUS ADMINISTRATION OF PENICILLIN G BENZATHINE WHICH HAS BEEN ASSOCIATED WITH CARDIORESPIRATORY ARREST AND DEATH. Prior to administration of this drug, carefully read the WARNINGS , ADVERSE REACTIONS , and DOSAGE AND ADMINISTRATION sections of the labeling.
Who it is for

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin C-R and other antibacterial drugs, Bicillin C-R should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. …

How to take it and how often
  • Streptococcal Infections Group A Infections of the upper-respiratory tract, skin and soft-tissue infections, scarlet fever, and erysipelas
  • The following doses are recommended: Adults and
  • Pediatric patients over 60 lbs. in weight: 2,400,000 units
  • Pediatric patients from 30 to 60 lbs.: 900,000 units to 1,200,000 units
  • Pediatric patients under 30 lbs.: 600,000 units
  • NOTE: Treatment with the recommended dosage is usually given at a single session using multiple IM sites when indicated
  • An alternative dosage schedule may be used, giving one-half (1/2) the total dose on day 1 and one-half (1/2) on day 3
  • This will also insure the penicillinemia required over a 10-day period; however, this alternate schedule should be used only when the physician can be assured of the patient's cooperation
  • Pneumococcal Infections (except pneumococcal meningitis) 600,000 units
  • Pediatric patients and 1,200,000 units
  • Adults, repeated every 2 or 3 days until the temperature is normal for 48 hours
  • Other forms of penicillin may be necessary for severe cases
  • Method of Administration Bicillin C-R is intended for Intramuscular Injection ONLY
  • Do not inject into or near an artery or nerve, or intravenously or admix with other intravenous solutions. (See WARNINGS section)
Children

(See INDICATIONS AND USAGE and DOSAGE AND ADMINISTRATION sections.)

Older adults

Clinical studies of penicillin G benzathine and penicillin G procaine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. …

While you are taking it
  • Inform patients that use of local anesthetics may cause methemoglobinemia, a serious condition that must be treated promptly
  • Advise patients or caregivers to seek immediate medical attention if they or someone in their care experience the following signs or symptoms: pale, gray, or blue colored skin (cyanosis); headache; rapid heart rate; shortness of breath; lightheadedness; or fatigue
  • Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. …
Talk to a doctor first if

A previous hypersensitivity reaction to any penicillin or to procaine is a contraindication.

Medicines it may not mix with

Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided. Concurrent administration of penicillin and probenecid increases and prolongs serum penicillin levels by decreasing the apparent volume of distribution and slowing the rate of excretion by competitively inhibiting renal tubular secretion of penicillin. …

Warnings

WARNING: NOT FOR INTRAVENOUS USE. DO NOT INJECT INTRAVENOUSLY OR ADMIX WITH OTHER INTRAVENOUS SOLUTIONS. THERE HAVE BEEN REPORTS OF INADVERTENT INTRAVENOUS ADMINISTRATION OF PENICILLIN G BENZATHINE WHICH HAS BEEN ASSOCIATED WITH CARDIORESPIRATORY ARREST AND DEATH. Prior to administration of this drug, carefully read the WARNINGS , ADVERSE REACTIONS , and DOSAGE AND ADMINISTRATION sections of the labeling. The combination of penicillin G benzathine and penicillin G procaine should only be prescribed for the indications listed in this insert. Anaphylaxis SERIOUS AND OCCASIONALLY FATAL HYPERSENSITIVITY (ANAPHYLACTIC) REACTIONS HAVE BEEN REPORTED IN PATIENTS ON PENICILLIN THERAPY. …

Possible side effects

As with other penicillins, untoward reactions of the sensitivity phenomena are likely to occur, particularly in individuals who have previously demonstrated hypersensitivity to penicillins or in those with a history of allergy, asthma, hay fever, or urticaria. The following adverse reactions have been reported with Bicillin C-R during post-marketing experience: Skin and Appendages: Stevens-Johnson syndrome (SJS) and drug reaction with eosinophilia and systemic symptoms (DRESS) (See WARNINGS .) The following have been reported with parenteral penicillin G (the active moiety in Bicillin C-R): General: Hypersensitivity reactions including the following: skin eruptions (maculopapular to exfoliat …

Pregnancy and breastfeeding

Pregnancy Teratogenic effects Reproduction studies performed in the mouse, rat, and rabbit have revealed no evidence of impaired fertility or harm to the fetus due to penicillin G. Human experience with the penicillins during pregnancy has not shown any positive evidence of adverse effects on the fetus. …

If you take too much

Penicillin in overdosage has the potential to cause neuromuscular hyperirritability or convulsive seizures.

How to store it

Store in a refrigerator, 2º to 8º (36º to 46ºF). Keep from freezing.

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2026-07-21.

Label for procaine benzylpenicillin and benzylpenicillin sodium, the active ingredient registered with NAFDAC.

Check your pack of Bicillin Injection## (strength format)

Add the expiry date on your pack for a full Trust Score.

3 free checks left today Official sources: NAFDAC · WHO · U.S. FDA · Health Canada · NLM

About Bicillin Injection## (strength format)

What is in Bicillin Injection## (strength format)?

Bicillin Injection## (strength format) contains Procaine Benzylpenicillin; Benzylpenicillin Sodium (3000000IU+1000000UI), as injection, according to its NAFDAC registration record.

Is Bicillin Injection## (strength format) registered with NAFDAC?

Yes. Bicillin Injection## (strength format) is listed on the NAFDAC register under registration number 04-3787, and its registration is active as of 28 October 2026.

Has Bicillin Injection## (strength format) been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Bicillin Injection## (strength format) in our automatically synced alert list.

How can I check that my pack of Bicillin Injection## (strength format) is genuine?

Run a free authenticity scan with the NAFDAC number 04-3787, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Bicillin Injection## (strength format)?

Follow your prescription or the leaflet in your pack. The official label says: Streptococcal Infections Group A Infections of the upper-respiratory tract, skin and soft-tissue infections, scarlet fever, and erysipelas. The following doses are recommended: Adults and pediatric patients over 60 lbs. in weight: 2,400,000 units. Pediatric patients from 30 to 60 lbs.: 900,000 units to 1,200,000 units. Pediatric patients under 30 lbs.: 600,000 units. NOTE: Trea…

What is Bicillin Injection## (strength format) used for?

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Bicillin C-R and other antibacterial drugs, Bicillin C-R should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the (Summarised from the official U.S. FDA label for procaine benzylpenicillin and benzylpenicillin sodium. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Bicillin Injection## (strength format)? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.